Pioglitazone alleviates oxygen and glucose deprivation-induced injury by up-regulation of miR-454 in H9c2 cells

OBJECTIVE(S): Pioglitazone, an anti-diabetic agent, has been widely used to treat type II diabetes. However, the effect of pioglitazone on myocardial ischemia reperfusion injury (MIRI) is still unclear. Herein, the objective of this study is to learn about the regulation and mechanism of pioglitazon...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Nianzi, Yang, Lin, Zhang, Qian, Zou, Chengwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281065/
https://www.ncbi.nlm.nih.gov/pubmed/30524679
http://dx.doi.org/10.22038/IJBMS.2018.29223.7063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281065/
https://www.ncbi.nlm.nih.gov/pubmed/30524679
http://dx.doi.org/10.22038/IJBMS.2018.29223.7063

Ejemplares similares